GlassScriptPhysician profile
Anna Mauro
NPI 1821618208
$1,427.28
in general payments reported to CMS, 2019-2025
12 companies · $821 in 2025
The $821 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $39.49 · 2024: $567 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $257.20 | 2024-2025 | Lapiplasty System 1 |
| Stryker Corporation | $236.53 | 2024 | Infinity, Ortholoc 3di, Claw II |
| Vertex Pharmaceuticals Incorporated | $174.22 | 2025 | Journavx |
| Surgenex LLC | $153.51 | 2025 | Renograft, Pellograft, Surmatrix |
| Pinnacle, INC | $149.45 | 2023-2025 | |
| Convatec INC. | $136.18 | 2024-2025 | Innovamatrix Ac |
| Biotissue Holdings INC. | $125.00 | 2024 | |
| Paratek Pharmaceuticals, INC. | $81.54 | 2025 | Nuzyra |
| Urgo Medical North America, LLC | $38.82 | 2024-2025 | Urgoclean Ag |
| Amgen INC. | $36.77 | 2025 | Krystexxa |
| Smith+Nephew, INC. | $21.64 | 2024 | Grafix Pl |
| Acumed LLC | $16.42 | 2024 | Acumed, Osteomed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Mauro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.